Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Telo Genomics Corp (TDSGF)

Telo Genomics Corp (TDSGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Telo Genomics Receives Approval from the Intellectual Property Ontario Program (IPON) Newsfile - Tue Nov 19, 7:56AM CST

Toronto, Ontario--(Newsfile Corp. - November 19, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
Telo Genomics Expands its Strategic Collaboration with Mayo Clinic Newsfile - Wed Oct 30, 7:48AM CDT

Toronto, Ontario--(Newsfile Corp. - October 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
Telo Genomics Presents New Performance Data for Its Smoldering Myeloma Prognostic Test Newsfile - Tue Oct 22, 8:02AM CDT

Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
Telo Genomics Assessing MRD Status in TELO-DMRD Study Newsfile - Tue Sep 10, 8:00AM CDT

Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
Telo Genomics Receives CLIA Certification Newsfile - Tue Aug 13, 7:58AM CDT

Toronto, Ontario--(Newsfile Corp. - August 13, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
Telo Genomics Announces Its TeloViewSMM Test Is Accepted as Laboratory Developed Test by CAP Newsfile - Tue Jun 18, 7:50AM CDT

Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
Telo Genomics Presents Proprietary Artificial Intelligence Methodologies at ASCO 2024 Newsfile - Wed Jun 12, 7:50AM CDT

Toronto, Ontario--(Newsfile Corp. - June 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ("Telo" or the "Company"), is pleased to announce that results of the development, validation...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
Telo Genomics Announces Publication of Results from Its Smoldering Myeloma Clinical Study in the American Journal of Hematology Newsfile - Thu May 30, 8:00AM CDT

Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company" or "Telo"), a biotech company developing the industry's leading telomere...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
Telo Genomics and Emery Pharma Announce Collaboration Newsfile - Wed May 15, 7:56AM CDT

Toronto, Ontario--(Newsfile Corp. - May 15, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)
Telo Genomics Receives Accreditation from College of American Pathologists Newsfile - Wed Apr 10, 7:52AM CDT

Toronto, Ontario--(Newsfile Corp. - April 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.0810 (-11.18%)
TELO.VN : 0.120 (+4.35%)

Barchart Exclusives

ELF’s Unusual Options Activity Is a Thing of Questionable Beauty Barchart - 57 minutes ago
E.L.F. Beauty’s options volume on Wednesday was 7x the 30-day average. The affordable makeup and skincare company’s unusual options activity stood out as one investor questioned its revenues. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot